KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) Inventory Average (2016 - 2026)

Gsk has reported Inventory Average over the past 18 years, most recently at $8.1 billion for Q1 2026.

  • For Q1 2026, Inventory Average rose 9.08% year-over-year to $8.1 billion; the TTM value through Mar 2026 reached $8.1 billion, up 9.08%, while the annual FY2025 figure was $7.6 billion, 7.49% up from the prior year.
  • Inventory Average for Q1 2026 was $8.1 billion at Gsk, roughly flat from $8.1 billion in the prior quarter.
  • Over five years, Inventory Average peaked at $8.2 billion in Q3 2025 and troughed at $3.6 billion in Q2 2022.
  • A 5-year average of $6.8 billion and a median of $7.0 billion in 2024 define the central range for Inventory Average.
  • Biggest five-year swings in Inventory Average: plummeted 58.69% in 2022 and later soared 86.29% in 2023.
  • Year by year, Inventory Average stood at $5.8 billion in 2022, then rose by 19.42% to $6.9 billion in 2023, then increased by 8.72% to $7.5 billion in 2024, then grew by 7.82% to $8.1 billion in 2025, then rose by 0.28% to $8.1 billion in 2026.
  • Business Quant data shows Inventory Average for GSK at $8.1 billion in Q1 2026, $8.1 billion in Q4 2025, and $8.2 billion in Q3 2025.